El pronóstico de la esquizofrenia.

Same author

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Schizophrenia research·2020

Same author

Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

Development and psychopathology·2020

Same author

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.

Schizophrenia research·2019

Same author

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

Schizophrenia research·2018

Same author

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.

Schizophrenia research·2018

Same author

Prospective clinical trial registration: not sufficient, but always necessary.

Anaesthesia·2018

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

El pronóstico de la esquizofrenia.

Videos de Conceptos Relacionados

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.

Prospective clinical trial registration: not sufficient, but always necessary.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

El pronóstico de la esquizofrenia.

Videos de Conceptos Relacionados

Artículos Relacionados

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis.

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.

Prospective clinical trial registration: not sufficient, but always necessary.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.